Insulin pen devices incorporate the insulin and syringe in a single unit and have been found to address some of the barriers to adherence, as compared to conventional vials/syringes. 2 Reasons ...

For the vial and syringe group, the total number of subcutaneous injections was converted to the total number of syringes used. In the insulin pen group, if the number of units of insulin consumed ...

Major players in the insulin pens, syringes, pumps, and injectors devices and equipment market are Novo Nordisk A/S, Eli Lilly and Company, Medtronic plc, Abbott, Insulet Corporation, Sanofi ...

How to Afford Insulin Pumps, Pens, Syringes, and More Medically reviewed by Alana Biggers, M.D., MPH — Written by Mike Hoskins — Updated on May 13, 2025 Insulin pricing ...

There are currently four main ways people can administer insulin: syringes, pens, pumps, and inhalers. How a person takes insulin can vary depending on their lifestyle, sugar levels, and what they ...

However, the insulin pen group had a larger decrease in HbA1c at 12 weeks than the syringe group (mean change, –1.53% vs. –0.81%; P = .02). No significant difference in HbA1c from 12 to 24 ...

Asche CV, Shane-McWhorter L, Raparla S. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence. Diabetes Technol Ther. 2010;12 Suppl 1:S101-S108. 7.

Studies have also shown that the use of insulin pens compared to vials and syringes results in reduced HbA 1c values, lower mean fasting blood glucose levels, improved medication adherence, ...

Major players in the insulin pens, syringes, pumps, and injectors devices and equipment market are Novo Nordisk A/S, Eli Lilly and Company, Medtronic plc, Abbott, Insulet Corporation, Sanofi, Roche ...